NDAORALTABLETPriority Review
Approved
Jun 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ERGAMISOL (levamisole hydrochloride) is an oral small-molecule anthelmintic and immunomodulator approved in 1990 for parasitic infections and certain malignancies. The drug works by stimulating immune function and directly eliminating parasitic worms. It is used in combination therapies and for select oncologic indications.
LOE Approaching
With LOE approaching and low competitive pressure (30%), roles on this product focus on lifecycle extension, generic transition management, and portfolio rationalization rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ERGAMISOL offers limited career growth due to zero linked job openings and LOE-approaching lifecycle status; roles focus on portfolio wind-down, generic management, and operational efficiency. This product is suited for professionals with turnaround or specialty expertise rather than those seeking high-growth opportunities.
Brand Manager (LOE specialty)Commercial Operations
Worked on ERGAMISOL at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.